Drugs Information:
Frovatriptan
Basic Information
|
||
ID | DDInter788 | |
Drug Type | small molecule | |
Molecular Formula | C14H17N3O | |
Molecular Weight | 243.304 | |
CAS Number | 158747-02-5 | |
Description | Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. | |
ATC Classification | N02CC07 | |
IUPAC Name | (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide | |
InChI | XPSQPHWEGNHMSK-SECBINFHSA-N | |
Canonical SMILES | CN[C@@H]1CCC2=C(C1)C1=C(N2)C=CC(=C1)C(N)=O | |
Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC |
Interactions with
Frovatriptan
Filter:
Severity level | ID | Name | Mechanism | Detail |
---|
Interactions with diseases
Filter:
Severity level | Disease name | Text | References |
---|
Interactions with foods
Filter:
Severity level | Food name | Description | Management | Mechanism | References |
---|
Interactions with compound preparation
Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
---|